Paolo Cavallo Perin - Concepedia

Author

Paolo Cavallo Perin

Also Known As

A. Tone, E. Kosugi, P C Perin, P Cavallo Perin, P. C. Perin, P. CAVALLO PERIN, P. Cavallo Perin, P.C. Perin, P.Cavallo Perin, Paolo Cavallo Perin

144

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Turin University College London University of Padua Imperial College London Azienda Ospedaliero Universitaria San Giovanni Battista

About

Paolo Cavallo Perin is an author at University of Turin specializing in medicine, diabetes, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.8K
2	Public Health	6	6	356
3	Health Sciences	4	4	134
4	Engineering	1	1	30
5	Natural Sciences	1	1	61

Paolo Cavallo Perin

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy Federica Barutta, Marinella Tricarico, Alessandro Corbelli, PLoS ONE Metabolic SyndromeTarget MrnasUrologyRenal DiseaseDiabetes Management	2013	307
Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe Anne Katrin Sjølie, Judith Stephenson, S J Aldington, Ophthalmology Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetesEye Tracking	1997	216
The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group M. Veglio, M. Borra, Linda Stevens, Diabetologia Diabetes ManagementDiabetes EpidemiologyCardiovascular DiseaseHealth PolicyQtc Interval Prolongation	1999	166
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy Federica Barutta, Alessandro Corbelli, Raffaella Mastrocola, Diabetes	2010	145
Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study Francesco Giorgino, Luigi Laviola, Paolo Cavallo Perin, Diabetologia UrologyRenal DiseaseDiabetes EpidemiologyMedicineDiabetes	2004	143
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy Federica Barutta, Fabiana Piscitelli, Silvia Pinach, Diabetes	2011	143
Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes Enrica Favaro, Andrea Carpanetto, Sara Lamorte, Diabetologia Regenerative MedicineType 1MedicineInsulin ManagementDiabetes	2014	129
Progression to Overt Nephropathy in Type 2 Diabetes Graziella Bruno, Franco Merletti, Annibale Biggeri, Diabetes Care	2003	119
Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes Elena Tarabra, Sara Giunti, Federica Barutta, Diabetes	2009	118
Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment Marianna Noale, Nicola Veronese, Paolo Cavallo Perin, Acta Diabetologica Oral Antidiabetic TreatmentDiabetes ManagementElderly PatientsGeriatricsMedicine	2015	99

Page 1